Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180)
Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293) . This antibody recognizes the SARS-CoV-2 Spike Protein RBD domain and inhibits the interaction between SARS-CoV-2 RBD and ACE2 with an IC50 of 0.98 μg/mL using SARS-CoV-2 Inhibitor Screening Kit.Pseudovirus assay shows that this antibody has potent neutralizing activity against pseudovirus bearing SARS-CoV-2 Spike protein.
Product Specifications
Background
Host
HEK293
Origin Species
Human
Target
Spike RBD
Conjugation
Unconjugated
Tag
Human IgG1 | Human Kappa
Stability
Purity
95%
Bioactivity
Format
Powder
Buffer
PBS, pH7.4
Additives
Trehalose
Shipping Conditions
RT
Storage Conditions
-20°C
Package Size
1mg*1
Product Datasheet
Https://www.acrobiosystems.com/static/main/products/pdf/ds/SPD-M180.pdf
Species
Human
CAS Number
9007-83-4
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items